Global and United States Next Generation Sequencing (NGS) Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Targeted Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Whole Genome Sequencing
1.3 Market by Application
1.3.1 Global Next Generation Sequencing (NGS) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic & Government Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing (NGS) Market Perspective (2016-2027)
2.2 Next Generation Sequencing (NGS) Growth Trends by Regions
2.2.1 Next Generation Sequencing (NGS) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Next Generation Sequencing (NGS) Historic Market Share by Regions (2016-2021)
2.2.3 Next Generation Sequencing (NGS) Forecasted Market Size by Regions (2022-2027)
2.3 Next Generation Sequencing (NGS) Industry Dynamic
2.3.1 Next Generation Sequencing (NGS) Market Trends
2.3.2 Next Generation Sequencing (NGS) Market Drivers
2.3.3 Next Generation Sequencing (NGS) Market Challenges
2.3.4 Next Generation Sequencing (NGS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing (NGS) Players by Revenue
3.1.1 Global Top Next Generation Sequencing (NGS) Players by Revenue (2016-2021)
3.1.2 Global Next Generation Sequencing (NGS) Revenue Market Share by Players (2016-2021)
3.2 Global Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencing (NGS) Revenue
3.4 Global Next Generation Sequencing (NGS) Market Concentration Ratio
3.4.1 Global Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Revenue in 2020
3.5 Next Generation Sequencing (NGS) Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencing (NGS) Product Solution and Service
3.7 Date of Enter into Next Generation Sequencing (NGS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing (NGS) Breakdown Data by Type
4.1 Global Next Generation Sequencing (NGS) Historic Market Size by Type (2016-2021)
4.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2022-2027)
5 Next Generation Sequencing (NGS) Breakdown Data by Application
5.1 Global Next Generation Sequencing (NGS) Historic Market Size by Application (2016-2021)
5.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Next Generation Sequencing (NGS) Market Size (2016-2027)
6.2 North America Next Generation Sequencing (NGS) Market Size by Type
6.2.1 North America Next Generation Sequencing (NGS) Market Size by Type (2016-2021)
6.2.2 North America Next Generation Sequencing (NGS) Market Size by Type (2022-2027)
6.2.3 North America Next Generation Sequencing (NGS) Market Size by Type (2016-2027)
6.3 North America Next Generation Sequencing (NGS) Market Size by Application
6.3.1 North America Next Generation Sequencing (NGS) Market Size by Application (2016-2021)
6.3.2 North America Next Generation Sequencing (NGS) Market Size by Application (2022-2027)
6.3.3 North America Next Generation Sequencing (NGS) Market Size by Application (2016-2027)
6.4 North America Next Generation Sequencing (NGS) Market Size by Country
6.4.1 North America Next Generation Sequencing (NGS) Market Size by Country (2016-2021)
6.4.2 North America Next Generation Sequencing (NGS) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Next Generation Sequencing (NGS) Market Size (2016-2027)
7.2 Europe Next Generation Sequencing (NGS) Market Size by Type
7.2.1 Europe Next Generation Sequencing (NGS) Market Size by Type (2016-2021)
7.2.2 Europe Next Generation Sequencing (NGS) Market Size by Type (2022-2027)
7.2.3 Europe Next Generation Sequencing (NGS) Market Size by Type (2016-2027)
7.3 Europe Next Generation Sequencing (NGS) Market Size by Application
7.3.1 Europe Next Generation Sequencing (NGS) Market Size by Application (2016-2021)
7.3.2 Europe Next Generation Sequencing (NGS) Market Size by Application (2022-2027)
7.3.3 Europe Next Generation Sequencing (NGS) Market Size by Application (2016-2027)
7.4 Europe Next Generation Sequencing (NGS) Market Size by Country
7.4.1 Europe Next Generation Sequencing (NGS) Market Size by Country (2016-2021)
7.4.2 Europe Next Generation Sequencing (NGS) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size (2016-2027)
8.2 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type
8.2.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type (2016-2027)
8.3 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application
8.3.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application (2016-2027)
8.4 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region
8.4.1 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Next Generation Sequencing (NGS) Market Size (2016-2027)
9.2 Latin America Next Generation Sequencing (NGS) Market Size by Type
9.2.1 Latin America Next Generation Sequencing (NGS) Market Size by Type (2016-2021)
9.2.2 Latin America Next Generation Sequencing (NGS) Market Size by Type (2022-2027)
9.2.3 Latin America Next Generation Sequencing (NGS) Market Size by Type (2016-2027)
9.3 Latin America Next Generation Sequencing (NGS) Market Size by Application
9.3.1 Latin America Next Generation Sequencing (NGS) Market Size by Application (2016-2021)
9.3.2 Latin America Next Generation Sequencing (NGS) Market Size by Application (2022-2027)
9.3.3 Latin America Next Generation Sequencing (NGS) Market Size by Application (2016-2027)
9.4 Latin America Next Generation Sequencing (NGS) Market Size by Country
9.4.1 Latin America Next Generation Sequencing (NGS) Market Size by Country (2016-2021)
9.4.2 Latin America Next Generation Sequencing (NGS) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size (2016-2027)
10.2 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type
10.2.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type (2016-2027)
10.3 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application
10.3.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application (2016-2027)
10.4 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country
10.4.1 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Next Generation Sequencing (NGS) Introduction
11.1.4 Illumina Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Pacific Biosciences of California
11.3.1 Pacific Biosciences of California Company Details
11.3.2 Pacific Biosciences of California Business Overview
11.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Introduction
11.3.4 Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.3.5 Pacific Biosciences of California Recent Development
11.4 Beijing Genomics Institute
11.4.1 Beijing Genomics Institute Company Details
11.4.2 Beijing Genomics Institute Business Overview
11.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Introduction
11.4.4 Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.4.5 Beijing Genomics Institute Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Next Generation Sequencing (NGS) Introduction
11.5.4 Qiagen Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.5.5 Qiagen Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Next Generation Sequencing (NGS) Introduction
11.6.4 Roche Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Details
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Next Generation Sequencing (NGS) Introduction
11.7.4 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.7.5 Agilent Technologies Recent Development
11.8 Perkinelmer
11.8.1 Perkinelmer Company Details
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer Next Generation Sequencing (NGS) Introduction
11.8.4 Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.8.5 Perkinelmer Recent Development
11.9 Genomatix
11.9.1 Genomatix Company Details
11.9.2 Genomatix Business Overview
11.9.3 Genomatix Next Generation Sequencing (NGS) Introduction
11.9.4 Genomatix Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.9.5 Genomatix Recent Development
11.10 PierianDx
11.10.1 PierianDx Company Details
11.10.2 PierianDx Business Overview
11.10.3 PierianDx Next Generation Sequencing (NGS) Introduction
11.10.4 PierianDx Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.10.5 PierianDx Recent Development
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Details
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Introduction
11.11.4 Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.11.5 Eurofins Scientific Recent Development
11.12 Gatc Biotech
11.12.1 Gatc Biotech Company Details
11.12.2 Gatc Biotech Business Overview
11.12.3 Gatc Biotech Next Generation Sequencing (NGS) Introduction
11.12.4 Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.12.5 Gatc Biotech Recent Development
11.13 Oxford Nanopore Technologies
11.13.1 Oxford Nanopore Technologies Company Details
11.13.2 Oxford Nanopore Technologies Business Overview
11.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Introduction
11.13.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.13.5 Oxford Nanopore Technologies Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Introduction
11.14.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 DNASTAR
11.15.1 DNASTAR Company Details
11.15.2 DNASTAR Business Overview
11.15.3 DNASTAR Next Generation Sequencing (NGS) Introduction
11.15.4 DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.15.5 DNASTAR Recent Development
11.16 Biomatters
11.16.1 Biomatters Company Details
11.16.2 Biomatters Business Overview
11.16.3 Biomatters Next Generation Sequencing (NGS) Introduction
11.16.4 Biomatters Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.16.5 Biomatters Recent Development
11.17 Partek
11.17.1 Partek Company Details
11.17.2 Partek Business Overview
11.17.3 Partek Next Generation Sequencing (NGS) Introduction
11.17.4 Partek Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.17.5 Partek Recent Development
11.18 New England Biolabs
11.18.1 New England Biolabs Company Details
11.18.2 New England Biolabs Business Overview
11.18.3 New England Biolabs Next Generation Sequencing (NGS) Introduction
11.18.4 New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.18.5 New England Biolabs Recent Development
11.18 Myriad Genetics
.1 Myriad Genetics Company Details
.2 Myriad Genetics Business Overview
.3 Myriad Genetics Next Generation Sequencing (NGS) Introduction
.4 Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
.5 Myriad Genetics Recent Development
11.20 Macrogen
11.20.1 Macrogen Company Details
11.20.2 Macrogen Business Overview
11.20.3 Macrogen Next Generation Sequencing (NGS) Introduction
11.20.4 Macrogen Revenue in Next Generation Sequencing (NGS) Business (2016-2021)
11.20.5 Macrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Targeted Sequencing
Table 3. Key Players of Whole Exome Sequencing
Table 4. Key Players of Whole Genome Sequencing
Table 5. Global Next Generation Sequencing (NGS) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Next Generation Sequencing (NGS) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Next Generation Sequencing (NGS) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Next Generation Sequencing (NGS) Market Share by Regions (2016-2021)
Table 9. Global Next Generation Sequencing (NGS) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Next Generation Sequencing (NGS) Market Share by Regions (2022-2027)
Table 11. Next Generation Sequencing (NGS) Market Trends
Table 12. Next Generation Sequencing (NGS) Market Drivers
Table 13. Next Generation Sequencing (NGS) Market Challenges
Table 14. Next Generation Sequencing (NGS) Market Restraints
Table 15. Global Next Generation Sequencing (NGS) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Next Generation Sequencing (NGS) Market Share by Players (2016-2021)
Table 17. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Sequencing (NGS) as of 2020)
Table 18. Ranking of Global Top Next Generation Sequencing (NGS) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Next Generation Sequencing (NGS) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Next Generation Sequencing (NGS) Product Solution and Service
Table 22. Date of Enter into Next Generation Sequencing (NGS) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2016-2021)
Table 26. Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Next Generation Sequencing (NGS) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Next Generation Sequencing (NGS) Revenue Market Share by Application (2016-2021)
Table 30. Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Next Generation Sequencing (NGS) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Next Generation Sequencing (NGS) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Next Generation Sequencing (NGS) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Next Generation Sequencing (NGS) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Next Generation Sequencing (NGS) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Next Generation Sequencing (NGS) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Next Generation Sequencing (NGS) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Next Generation Sequencing (NGS) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Next Generation Sequencing (NGS) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Next Generation Sequencing (NGS) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Next Generation Sequencing (NGS) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Next Generation Sequencing (NGS) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Next Generation Sequencing (NGS) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Next Generation Sequencing (NGS) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Next Generation Sequencing (NGS) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Next Generation Sequencing (NGS) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Next Generation Sequencing (NGS) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Next Generation Sequencing (NGS) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Illumina Company Details
Table 63. Illumina Business Overview
Table 64. Illumina Next Generation Sequencing (NGS) Product
Table 65. Illumina Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 66. Illumina Recent Development
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific Next Generation Sequencing (NGS) Product
Table 70. Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. Pacific Biosciences of California Company Details
Table 73. Pacific Biosciences of California Business Overview
Table 74. Pacific Biosciences of California Next Generation Sequencing (NGS) Product
Table 75. Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 76. Pacific Biosciences of California Recent Development
Table 77. Beijing Genomics Institute Company Details
Table 78. Beijing Genomics Institute Business Overview
Table 79. Beijing Genomics Institute Next Generation Sequencing (NGS) Product
Table 80. Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 81. Beijing Genomics Institute Recent Development
Table 82. Qiagen Company Details
Table 83. Qiagen Business Overview
Table 84. Qiagen Next Generation Sequencing (NGS) Product
Table 85. Qiagen Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 86. Qiagen Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Next Generation Sequencing (NGS) Product
Table 90. Roche Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 91. Roche Recent Development
Table 92. Agilent Technologies Company Details
Table 93. Agilent Technologies Business Overview
Table 94. Agilent Technologies Next Generation Sequencing (NGS) Product
Table 95. Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 96. Agilent Technologies Recent Development
Table 97. Perkinelmer Company Details
Table 98. Perkinelmer Business Overview
Table 99. Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 100. Perkinelmer Recent Development
Table 101. Genomatix Company Details
Table 102. Genomatix Business Overview
Table 103. Genomatix Next Generation Sequencing (NGS) Product
Table 104. Genomatix Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 105. Genomatix Recent Development
Table 106. PierianDx Company Details
Table 107. PierianDx Business Overview
Table 108. PierianDx Next Generation Sequencing (NGS) Product
Table 109. PierianDx Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 110. PierianDx Recent Development
Table 111. Eurofins Scientific Company Details
Table 112. Eurofins Scientific Business Overview
Table 113. Eurofins Scientific Next Generation Sequencing (NGS) Product
Table 114. Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 115. Eurofins Scientific Recent Development
Table 116. Gatc Biotech Company Details
Table 117. Gatc Biotech Business Overview
Table 118. Gatc Biotech Next Generation Sequencing (NGS) Product
Table 119. Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 120. Gatc Biotech Recent Development
Table 121. Oxford Nanopore Technologies Company Details
Table 122. Oxford Nanopore Technologies Business Overview
Table 123. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Product
Table 124. Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 125. Oxford Nanopore Technologies Recent Development
Table 126. Bio-Rad Laboratories Company Details
Table 127. Bio-Rad Laboratories Business Overview
Table 128. Bio-Rad Laboratories Next Generation Sequencing (NGS) Product
Table 129. Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 130. Bio-Rad Laboratories Recent Development
Table 131. DNASTAR Company Details
Table 132. DNASTAR Business Overview
Table 133. DNASTAR Next Generation Sequencing (NGS) Product
Table 134. DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 135. DNASTAR Recent Development
Table 136. Biomatters Company Details
Table 137. Biomatters Business Overview
Table 138. Biomatters Next Generation Sequencing (NGS) Product
Table 139. Biomatters Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 140. Biomatters Recent Development
Table 141. Partek Company Details
Table 142. Partek Business Overview
Table 143. Partek Next Generation Sequencing (NGS) Product
Table 144. Partek Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 145. Partek Recent Development
Table 146. New England Biolabs Company Details
Table 147. New England Biolabs Business Overview
Table 148. New England Biolabs Next Generation Sequencing (NGS) Product
Table 149. New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 150. New England Biolabs Recent Development
Table 151. Myriad Genetics Company Details
Table 152. Myriad Genetics Business Overview
Table 153. Myriad Genetics Next Generation Sequencing (NGS) Product
Table 154. Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 155. Myriad Genetics Recent Development
Table 156. Macrogen Company Details
Table 157. Macrogen Business Overview
Table 158. Macrogen Next Generation Sequencing (NGS) Product
Table 159. Macrogen Revenue in Next Generation Sequencing (NGS) Business (2016-2021) & (US$ Million)
Table 160. Macrogen Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Next Generation Sequencing (NGS) Market Share by Type: 2020 VS 2027
Figure 2. Targeted Sequencing Features
Figure 3. Whole Exome Sequencing Features
Figure 4. Whole Genome Sequencing Features
Figure 5. Global Next Generation Sequencing (NGS) Market Share by Application: 2020 VS 2027
Figure 6. Academic & Government Research Institutes Case Studies
Figure 7. Pharmaceutical Companies Case Studies
Figure 8. Biotechnology Companies Case Studies
Figure 9. Hospitals & Clinics Case Studies
Figure 10. Next Generation Sequencing (NGS) Report Years Considered
Figure 11. Global Next Generation Sequencing (NGS) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Next Generation Sequencing (NGS) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Next Generation Sequencing (NGS) Market Share by Regions: 2020 VS 2027
Figure 14. Global Next Generation Sequencing (NGS) Market Share by Regions (2022-2027)
Figure 15. Global Next Generation Sequencing (NGS) Market Share by Players in 2020
Figure 16. Global Top Next Generation Sequencing (NGS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Sequencing (NGS) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Next Generation Sequencing (NGS) Revenue in 2020
Figure 18. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2016-2021)
Figure 19. Global Next Generation Sequencing (NGS) Revenue Market Share by Type (2022-2027)
Figure 20. North America Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Next Generation Sequencing (NGS) Market Share by Type (2016-2027)
Figure 22. North America Next Generation Sequencing (NGS) Market Share by Application (2016-2027)
Figure 23. North America Next Generation Sequencing (NGS) Market Share by Country (2016-2027)
Figure 24. United States Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Next Generation Sequencing (NGS) Market Share by Type (2016-2027)
Figure 28. Europe Next Generation Sequencing (NGS) Market Share by Application (2016-2027)
Figure 29. Europe Next Generation Sequencing (NGS) Market Share by Country (2016-2027)
Figure 30. Germany Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Next Generation Sequencing (NGS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Next Generation Sequencing (NGS)